Sirivisoot, Sirintra <br/><br/>
Monitoring minimal residual disease in canine lymphomas treated with modified L-COP or L-CHOP protocols.  [electronic resource] 

 -  Acta veterinaria Hungarica  03 2018 
 - 66-84 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0236-6290 
<br/><br/><label>Standard No.: </label>10.1556/004.2018.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Dog Diseases--drug therapy<br/>Dogs<br/>Lymphoma--drug therapy<br/>Polymerase Chain Reaction--methods